# AZmed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/azmed

- Industry: Software
- Headquarters: Paris, France
- Website: www.azmed.co
- Total disclosed funding: $1.7M
- Latest round: Series A (Feb 20, 2024)
- Investors on record: 3

## About

Founded in 2018 and based in Paris, France, AZmed operates as a software company. The company was founded by its CEO Julien Vidal, CTO Alexandre Attia, and CMO Elie Zerbib-Attal. In February 2024, AZmed raised EUR 15 million in Series A funding from Maison Worms and Tempact Ventures.

The company’s product line includes Rayvolve, which is an artificial intelligence-based software that detects all types of bone lesions on standard radiographs.

The company plans to use the funds raised in February 2024 to expand its market across the United States, Middle East, Africa, and Asia, as well as develop its artificial intelligence technology.

## Funding rounds

- Series A, Feb 20, 2024, $1.7M — Maison Worms, Techstars, Teampact Ventures

## Investors

- Maison Worms — Series A
- Techstars (https://capitalatlas.ai/funds/techstars) — Series A
- Teampact Ventures (https://capitalatlas.ai/funds/teampact-ventures) — Series A